LumiraDx Investor Presentation Deck

2 Consolidate Multiple POC Instruments to a Single Lab Comparable Platform ххх X Respiratory Immunoassay Coagulation Diabetes, Inflammation NEAR TERM Able to move most European customers from 3 → 1 Platform with INR, COVID Ag, Flu A/B, RSV, CRP and HbA1c lumiraDx™ Respiratory Molecular Diabetes, Cardiovascular Copyright © 2022 Lumirax Ltd. All Rights Reserved, Worldwide Cardiac, Blood gas, Metabolic 18-24 MONTHS Able to move most US and European customers 6 → 1 Platform with US authorizations and addition of molecular respiratory, lipids, electrolytes, and cardiac content 32

View entire presentation